Literature DB >> 14601717

Community-acquired pneumonia in the elderly.

Vladimir Kaplan1, Derek C Angus.   

Abstract

CAP is traditionally considered a medical disease, and is managed with intravenous fluids and antibiotics on medical floors. Recent cost-containment efforts have shifted the provision of care to the outpatient settings, and only those with most severe disease and multiple comorbid illnesses are admitted to hospitals. Therefore, the proportion of hospitalized patients with severe CAP that need intensive care and life support is increasing. Furthermore, the incidence of severe CAP is also rising due to disproportionate growth of the elderly population that is most vulnerable to this deadly disease. Many of these elderly patients have advanced underlying diseases, and CAP might often be a terminal event superimposed on an underlying chronic debilitating illness. As ICU physicians, we need to be familiar with this disease, its complications, and its prognosis to provide intensive care in a timely and rational fashion in some patients, and refrain from life support in others. Just as prior efforts have sought to improve and standardize criteria for hospital admission, future efforts should aim to improve and standardize decisions regarding intensive care and life support in these very sick elderly patients. Future efforts in the management of CAP need to consider the postdischarge period where most deaths occur. Prevention is an important issue especially for those at high risk for CAP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14601717     DOI: 10.1016/s0749-0704(03)00057-5

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  9 in total

1.  Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in São Paulo State, Brazil.

Authors:  Joao Tonolio Neto; Gabriela Tannus Branco de Araujo; Anna Gagliardi; Amanda Pinho; Laure Durand; Marcelo Fonseca
Journal:  Hum Vaccin       Date:  2011-10-01

2.  Aging, imbalanced inflammation and viral infection.

Authors:  Daniel R Goldstein
Journal:  Virulence       Date:  2010 Jul-Aug       Impact factor: 5.882

Review 3.  Role of aging on innate responses to viral infections.

Authors:  Daniel R Goldstein
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-10-31       Impact factor: 6.053

4.  Efficacy of a vaccine that links viral epitopes to flagellin in protecting aged mice from influenza viral infection.

Authors:  Jin Leng; Heather W Stout-Delgado; Uma Kavita; Andrea Jacobs; Jie Tang; Wei Du; Lynda Tussey; Daniel R Goldstein
Journal:  Vaccine       Date:  2011-08-18       Impact factor: 3.641

5.  Aging promotes neutrophil-induced mortality by augmenting IL-17 production during viral infection.

Authors:  Heather W Stout-Delgado; Wei Du; Anushree C Shirali; Carmen J Booth; Daniel R Goldstein
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

6.  Attenuated response of aged mice to respiratory Francisella novicida is characterized by reduced cell death and absence of subsequent hypercytokinemia.

Authors:  Chris A Mares; Jyotika Sharma; Sandra S Ojeda; Qun Li; Jocelyn A Campos; Elizabeth G Morris; Jacqueline J Coalson; Judy M Teale
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

7.  Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy.

Authors:  Ayman M Noreddin; Walid F Elkhatib; Kenji M Cunnion; George G Zhanel
Journal:  Drug Healthc Patient Saf       Date:  2011-10-07

Review 8.  Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.

Authors:  John W Jackson; Sebastian Schneeweiss; Tyler J VanderWeele; Deborah Blacker
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

9.  Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia.

Authors:  Ales Tichopad; Craig Roberts; Igor Gembula; Petr Hajek; Anna Skoczynska; Waleria Hryniewicz; Karina Jahnz-Rozyk; Roman Prymula; Ivan Solovič; Vitězslav Kolek
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.